Regulation

Idaho Amendment Would Strip Voters of Cannabis Legalization Power

mm
Add MyCannabis.com to your preferred sources on Google

Idaho’s Republican-dominated legislature has placed voters in an unusual position: asking them to permanently surrender their own ability to decide drug policy through ballot initiatives. The state’s Legislative Council—a bicameral panel of legislative leadership—approved the final ballot language on June 4, 2026 for a constitutional amendment that would give the legislature exclusive authority over marijuana and other psychoactive substances, foreclosing the citizen-initiative route.

If a majority of voters approve it in November, that authority would be written permanently into the Idaho Constitution—reversible only if the legislature itself chose to refer another amendment to voters.

What the Amendment Would Do

The measure asks voters to change the state constitution so that only the legislature can authorize the growing, distribution, possession, prescribing, or use of marijuana, narcotics, or other psychoactive substances. It does not alter Idaho’s existing cannabis prohibitions—those remain. What it extinguishes is the initiative pathway: Idahoans would lose the ability to organize a petition campaign and put drug policy changes directly to a popular vote.

The Idaho House passed the resolution 58-10 in March 2025, and the Senate followed at 29-6—both margins clearing the two-thirds supermajority Idaho requires to refer a constitutional amendment to a general election ballot. The measure was driven by the State Affairs committees in both chambers.

The Legislative Council’s role this month was specific: under Idaho law, the council must approve a statement of purpose and meaning, plus arguments for and against, which the Idaho Secretary of State will then include in a voter pamphlet mailed to every household in the state before the November 3, 2026 general election.

The council’s approved statement: “This proposed constitutional amendment would give the Legislature exclusive authority to legalize marijuana, narcotics, or other psychoactive substances in the State of Idaho.”

That language went through revision. The original draft told voters the legislature — “but not the people” — would hold this authority. House Majority Leader Jason Monks of Meridian argued the phrase constituted an argument against rather than a neutral explanation; Senate Minority Leader Melissa Wintrow countered that describing what voters give up is precisely what a statement of purpose requires. The council voted along party lines to remove the contested language. The approved statement describes what the legislature gains; what voters relinquish did not make the final cut.

A Medical Cannabis Initiative in the Balance

The constitutional amendment is headed to a ballot where a competing measure may also appear.

The Natural Medicine Alliance of Idaho reported submitting more than 150,000 signatures for the Idaho Medical Cannabis Act, a citizen initiative that would create a regulated medical marijuana program in the state. County clerks are working through the verification process to determine whether the campaign has cleared the required threshold: signatures from at least 6 percent of registered voters, distributed across at least 18 of the state’s 35 legislative districts, as the Idaho Secretary of State requires for ballot qualification.

If the initiative qualifies alongside the constitutional amendment, voters in November would face a structural conflict. Approving the constitutional amendment while also approving the medical cannabis initiative would pit a higher-order constitutional rule against an ordinary statute. Under Idaho’s constitutional framework, the amendment would carry superior authority—meaning a yes vote on both measures could effectively nullify the medical cannabis statute voters also just approved. Whether that interaction applies to a statute passed simultaneously on the same ballot is among the legal questions Idaho courts would likely need to address.

The Idaho legislature has not left its position ambiguous. Beyond the constitutional amendment, lawmakers this session separately advanced a resolution urging voters to reject the medical cannabis petition.

Idaho’s Remaining Holdout Status

Idaho remains among the smallest group of states with no cannabis program at any level—no medical access, no adult-use market, no decriminalization. The broader national pattern has moved consistently toward some form of legal access, but Idaho’s legislature has moved in the opposite direction, tightening possession penalties and now seeking to constitutionalize that posture before voters can change it.

The medical cannabis campaign has commissioned polling indicating broad public support for some form of legal access, including majority support among Republican-identified voters. But in a state where the legislature cleared two-thirds supermajorities on this issue in both chambers, popular sentiment and legislative posture are clearly not aligned.

The November 3, 2026 election will determine whether Idaho voters, given the explicit choice, endorse their legislature’s effort to lock that posture into the state constitution—or choose, while they still can, to keep the initiative process available.

Ava Morales is an AI-generated analyst at MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.